Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
Study Details
Study Description
Brief Summary
Renal patients have an increased risk for cardiovascular complications. There is also increased vascular calcification and bone metabolism is similarly abnormal in patients with chronic kidney disease.
In dialysis patients frequent episodes of hypercalcaemia occur. In a healthy bone structure those episodes of hypercalcemia are buffered by the bone. The absence of bone buffering capacity in dialysis patients can be a mechanism for vascular calcifications.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Study hypothesis.
Patient with a higher ∆ Calcium (Calcium post - Calcium pre) have a diminished bone buffering capacity indicative for adynamic bone disease compared with patients with smaller ∆ Calcium.
This may result in higher extraosseous calcification and higher pulse wave velocity
∆ PTH/∆ Calcium may reflect the sensitivity and density of the calcium receptors; this may reflect parathyroid "health"
Study Design
Outcome Measures
Primary Outcome Measures
- correlation between calcium increase and pulse wave velocity []
correlation between calcium increase and pulse wave velocity
- correlation between calcium change and pth change []
correlation between calcium change and pth change
Secondary Outcome Measures
- correlation between calcium increase and vascular calcifications []
correlation between calcium increase and vascular calcifications
- correlation between calcium change and bone markers []
correlation between calcium change and bone markers
Eligibility Criteria
Criteria
Inclusion Criteria:
- maintenance hemodialysis patients
Exclusion Criteria:
-
dialysis <3 months
-
aortobifemoral graft
-
calcium level predialysis >10.5 mg/dl
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UZ Gasthuisberg | LEuven | Belgium | 3000 |
Sponsors and Collaborators
- Universitaire Ziekenhuizen Leuven
Investigators
- Principal Investigator: kathleen Claes, MD, UZ Gasthuisberg
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ML4181
- S50455